login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VIVOS THERAPEUTICS INC (VVOS) Stock News
USA
- NASDAQ:VVOS -
US92859E2072
-
Common Stock
2.36
USD
-0.11 (-4.45%)
Last: 11/4/2025, 8:00:02 PM
2.5142
USD
+0.15 (+6.53%)
Pre-Market:
11/5/2025, 8:00:02 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VVOS Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Zacks Investment Research
- Mentions:
ZTS
Zoetis (ZTS) Surpasses Q3 Earnings Estimates
a month ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
2 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
2 months ago - By: Benzinga
- Mentions:
CSCI
EVOK
NXL
ZYME
...
12 Health Care Stocks Moving In Friday's After-Market Session
3 months ago - By: The Motley Fool
Vivos Reports 7% Sales Drop
3 months ago - By: The Motley Fool
Vivos Therapeutics Unveils New Model
7 months ago - By: Benzinga
Earnings Outlook For Vivos Therapeutics
3 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
3 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
3 months ago - By: Zacks Investment Research
- Mentions:
LYRA
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance
4 months ago - By: Vivos Therapeutics, Inc
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
5 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
6 months ago - By: Zacks Investment Research
- Mentions:
PRPH
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
6 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
6 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
6 months ago - By: Zacks Investment Research
- Mentions:
NKTR
Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates
6 months ago - By: Yahoo Finance
- Mentions:
TTWO
MAT
SRAD
IRWD
...
Take-Two price target lowered to $236 from $240 at BMO Capital
6 months ago - By: Zacks Investment Research
- Mentions:
IRWD
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
7 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
7 months ago - By: Zacks Investment Research
- Mentions:
LYRA
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates
7 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
7 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
8 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
9 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
11 months ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
a year ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
a year ago - By: Vivos Therapeutics, Inc
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Please enable JavaScript to continue using this application.